Results 11 to 20 of about 12,861 (156)
Veterinary Dermatology, Volume 34, Issue 4, Page 348-354, August 2023., 2023 Background – Glycerinated allergen extracts contain 50% glycerin, an excellent preservative. While glycerin is a recognised irritant in humans, the utility of glycerinated extracts for intradermal testing has not been validated in dogs. Hypothesis/Objective – To determine and compare the effects of glycerin on immediate cutaneous reactions to ...
Frane Banovic, Cheryl Vargo, Tara Denley
wiley +1 more source
Veterinary Dermatology, Volume 34, Issue 3, Page 222-234, June 2023., 2023 Background – Mycophenolate mofetil (MMF) is the prodrug of mycophenolic acid (MPA) which acts as an immunosuppressive agent. During the biotransformation of MMF to MPA, additional metabolites including MPA phenol glucuronide (MPAG), MPA acyl glucuronide (AcMPAG) and MPA phenol glucoside (MPG) are formed.
Dylan L. Burroughs +6 more
wiley +1 more source
Rare Metals, Volume 45, Issue 2, February 2026.ABSTRACT Photocatalytic molecular oxygen (O2) activation provides a sustainable approach to produce singlet oxygen (1O2) for organic contaminants detoxification. However, the charge carriers‐involved pathway usually suffers from unsatisfactory 1O2 production efficiency owing to energy loss caused by photogenerated hole‐mediated superoxide species (•O2−
Yan‐Biao Shi +8 more
wiley +1 more source
Topical and transdermal botanical formulations of the Chinese pharmacopoeia—A review
Phytotherapy Research, Volume 38, Issue 9, Page 4716-4735, September 2024.Abstract In pharmaceutics, ingredients are classified as active ingredients and excipients. In topical/transdermal phytomedicines, an ingredient may serve both functions. Published information on these dual‐purpose ingredients and their pharmacological relevance is limited.
Jingyi Gu +3 more
wiley +1 more source
Pharmacology of drugs used in autoimmune dermatopathies in cats and dogs: A narrative review
Veterinary Dermatology, Volume 35, Issue 4, Page 453-476, August 2024.Immunosuppressive drugs are the mainstay of treatment for many feline and canine autoimmune skin diseases, either as monotherapy or in combination with other drugs. Treatment with these drugs is often lifelong and may have long‐term consequences on the affected animal's overall quality of life.
Heng L. Tham, Jennifer L. Davis
wiley +1 more source
Gongye shui chuli, 2020 对比了SBR与SBR-HASP系统对含苯酚废水的去除效果。由于腐殖活性污泥的作用，SBR-HASP系统对苯酚的去除效能要高于传统的SBR系统。对高浓度含苯酚废水处理工艺进行优化，与蛋白胨、苯酚作碳源相比，蛋白胨、甲醇和苯酚为碳源时对污泥有良好的驯化效果。
魏宏艳, 宋玮华
doaj
Gongye shui chuli, 2013 研究了高铁酸钾(K2FeO4)及高铁酸钾与次氯酸钠(NaClO)联用氧化分解废水中苯酚的效果,考察了K2FeO4和NaClO投加量、氧化反应时间和pH对苯酚和CODCr去除率的影响。结果表明:K2FeO4与NaClO联用处理苯酚废水存在明显的协同作用,当初始苯酚质量浓度为50 mg/L,pH为5左右,氧化反应时间为30 min,K2FeO4、NaClO投加量分别为1.5、0.3 g/L时,苯酚和CODCr去除率分别高达98%和68%以上,与单独使用K2FeO4相比,苯酚和CODCr去除率分别增加约5 ...
周建红, 李军, 令玉林, 李方文
doaj
Gongye shui chuli, 2016 以钛片为基底,SnO2+Sb2O5为中间层,自制氧化铅电极用于苯酚的电化学降解。试验结果表明,自制电极具有良好的苯酚去除效果:在室温为15℃,电极间距为15 mm,电流密度为16 mA/cm2,苯酚溶液pH为6.3,导电介质Na2SO4浓度为0.25 mol/L时,电解300 mL初始质量浓度为100 mg/L的苯酚,4 h后去除率可达91.89%。研究降解过程中苯酚初始浓度、pH、导电介质、电流密度、电极间距等因素对苯酚降解过程的影响。在此基础上对苯酚降解影响较大的初始浓度、pH、电流密度3个因素优化,
金贻芳, 于萍, 罗运柏
doaj
Gongye shui chuli, 2015 采用介质阻挡放电等离子体/微曝气技术协同处理苯酚废水,考察放电电压、放电时间、溶液初始浓度及曝气量对苯酚处理效果的影响。研究结果表明:苯酚降解率随放电时间增加、苯酚初始浓度减小而提高;曝气量为150 mL/min时,苯酚降解率为51.8%。采用介质阻挡放电等离子体/微曝气协同工艺处理苯酚废水,与单独使用介质阻挡放电等离子体工艺相比,苯酚降解率提高了15%~20.4%。
王红涛, 吕永康
doaj
, 2011 本发明是以苯为原料，氧气为氧化剂，乙腈为溶剂，利用含钒催化剂，在有机小分子助催化和共还原作用下由苯一步直接羟基化制苯酚的方法。其特点是催化剂原料易得，氧源廉价，反应速度快，苯酚收率较高，选择性佳 ...
李军, 吕迎, 陈佳琦, 高爽
core